All Cosmos Bio-Tech Holding Corporation (4148.TW) TAI
32.40
+1.4(+4.52%)
Currency In TWD
- General
- Statistics
- Historical Data
- Profile
- Financials
Valuation
| Market Cap | 3.46B |
| Enterprise Value | 2.62B |
| P/E Ratio | 40.39 |
| PEG Ratio | 1.78 |
| Price/Sales Ratio | 0.73 |
| Price/Book Ratio | 2.14 |
| Enterprise/Revenue | 0.37 |
| Enterprise/EBITDA | 3.11 |
Fiscal Year
| Fiscal Year | December 31, 2025 |
| Most Recent Quarter | March 31, 2026 |
Profitability
| Profit Margin | 0.05 |
| Operating Margin | 0.1 |
Management Effectiveness
| Return On Assets | 0.03 |
| Return On Equity | 0.06 |
Income Statement
| Revenue | 2.95B |
| Revenue/Share | 15.93 |
| Gross Profit | 829.47M |
| EBITDA | 362.56M |
| Net Income | 153M |
| Diluted EPS | 2.28 |
Balance Sheet
| Total Cash | 1.54B |
| Total Cash/Share | 8.38 |
| Total Debt | 285.38M |
| Total Debt/Equity | 0.1 |
| Current Ratio | 4.73 |
| Book Value Per Share | 18.69 |
Price History
| 52-Week Change | -28.43 |
| 52-Week High | 45.33 |
| 52-Week Low | 30.1 |
| Moving Average 50 Days | 37.55 |
| Moving Average 200 Days | 38.85 |
Statistics
| Average Volume | 104,844 |
| Shares Outstanding | 67.24M |
| % Held by Institutions | N/A |
Dividend And Splits
| Trailing Annual Dividend Rate | 0.5 |
| Trailing Annual Dividend Yield | 1.57 |
| Payout Ratio | 0.22 |
| Last Split Factor | 21:20 |
| Last Split Date | August 14, 2025 |
